VEGF Genotype and Allele Frequency of Diabetes Mellitus and Diabetic retinopathy in Lahore, Pakistan: Genotype of Diabetes Mellitus and Diabetic retinopathy

Samra Anees; Saima Shareef; Muhammad Roman; Shah Jahan

doi:10.54393/fbt.v2i02.18

Authors

Samra Anees Department of Zoology, Lahore College for Women University Lahore, Pakistan
Saima Shareef Department of Zoology, Lahore College for Women University Lahore, Pakistan
Muhammad Roman Department of Immunology, University of Health Sciences Lahore, Pakistan
Shah Jahan Department of Immunology, University of Health Sciences Lahore, Pakistan

DOI:

https://doi.org/10.54393/fbt.v2i02.18

Keywords:

Diabetic Retinopathy, Diabetes Mellitus, Genotype, Allele

Abstract

Diabetic retinopathy is characterized as basement membrane (BM) thickening, pericyte loss, endothelial cell (EC) dysfunction, microaneurysms, microvascular infarcts and neovascularization in a patient with diabetic retinopathy. Objectives: To determine the VEGF genotype and allele frequency of diabetes mellitus and diabetic retinopathy in Lahore, Pakistan. Methods: A total of 100 blood samples were taken including diabetes mellitus (50) and diabetic retinopathy patients (50). Diseased and control subjects were selected for blood sampling. Demographic and clinical characteristics was evaluated. The BMI, HbA1c and the blood pressure of both groups were also examined. The VEGF genotype and allele frequency of diabetes mellitus and diabetic retinopathy was done. The statistical analysis was done by chi-square test and SPSS to study significant differences in control and diabetic retinopathy subjects. Results: The normal estimation of DM group was 46.18 ± 1.23 years while of DR class was 52.86 ± 1.36 years. The mean value of BMI of DM group was 26.0±0.62 while of DR group was 26.57±0.70.

DD genetic mutation was substantially higher in diabetic retinopathy bunch (p<0.05) relative to the II gene mutation, the huge contrasts (p<0.05) were seen in diabetic group. Conclusions: This study concluded that Vascular endothelial growth factor gene was detected in both group of diabetes. In retinopathy people with T2DM the substantial elevated VEGF DD genetic variation was seen relative to retinopathy people without diabetes.

References

Kharroubi AT, Darwish HM. Diabetes mellitus: The epidemic of the century. World journal of diabetes. 2015 Jun; 6(6): 850-67. doi: 10.4239/wjd.v6.i6.850

American Diabetes Association. Standards of medical care in diabetes-2017 abridged for primary care providers. Clinical diabetes: a publication of the American Diabetes Association. 2017 Jan; 35(1): 5. doi: 10.2337/cd16-0067

Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinology and Metabolism Clinics. 2010 Sep; 39(3): 481-97. doi: 10.1016/j.ecl.2010.05.011

Daneman D. Type 1 diabetes. The Lancet. 2006 Mar; 367(9513): 847-58. doi: 10.1016/S0140-6736(06)68341-4

Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. Bmj. 2004 Mar; 328(7442): 750-4. doi: 10.1136/bmj.328.7442.750

Shera AS, Basit A, Fawwad A, Hakeem R, Ahmedani MY, Hydrie MZ, et al. Pakistan National Diabetes Survey: prevalence of glucose intolerance and associated factors in the Punjab Province of Pakistan. Primary care diabetes. 2010 Jul; 4(2): 79-83. doi: 10.1016/j.pcd.2010.01.003

Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinical practice. 2017 Jun; 128: 40-50. doi: 10.1016/j.diabres.2017.03.024

Misra A and Bloomgarden Z. Metabolic memory: Evolving concepts. Journal of diabetes. 2017 Dec; 10(3): 186-7. doi: 10.1111/1753-0407.12622

Silander K, Tang H, Myles S, Jakkula E, Timpson NJ, Cavalli-Sforza L, et al. Worldwide patterns of haplotype diversity at 9p21. 3, a locus associated with type 2 diabetes and coronary heart disease. Genome medicine. 2009 Dec; 1(5): 1-7. doi: 10.1186/gm51

Freedman BI, Bostrom M, Daeihagh P, Bowden DW. Genetic factors in diabetic nephropathy. Clinical Journal of the American Society of Nephrology. 2007 Nov; 2(6): 1306-16. doi: 10.2215/CJN.02560607

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes research and clinical practice. 2010 Jan; 87(1): 4-14. doi: 10.1016/j.diabres.2009.10.007

Wong TY, Gemmy CC, Larsen M, Sharma S, Rafael S. Erratum: Diabetic Retinopathy. Nature Reviews: Disease Primers. 2016; 2(1). doi: 10.1038/nrdp.2016.30

Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. The lancet global health. 2013 Dec; 1(6): e339-49. doi: 10.1016/S2214-109X(13)70113-X

Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes care. 2012 Mar; 35(3): 556-64. doi: 10.2337/dc11-1909

Mumtaz SN, Fahim MF, Arslan M, Shaikh SA, Kazi U, Memon MS. Prevalence of diabetic retinopathy in Pakistan; A systematic review. Pakistan journal of medical sciences. 2018 Mar; 34(2): 493-500. doi: 10.12669/pjms.342.13819

Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Progress in retinal and eye research. 2003 Jan; 22(1): 1-29. doi: 10.1016/S1350-9462(02)00043-5

Haas P, Steindl K, Aggermann T, Schmid-Kubista K, Krugluger W, Hageman GS, et al. Serum VEGF and CFH in exudative age-related macular degeneration. Current eye research. 2011 Feb; 36(2): 143-8. doi: 10.3109/02713683.2010.533808

Perrin RM, Konopatskaya O, Qiu Y, Harper S, Bates DO, Churchill AJ. Diabetic retinopathy is associated with a switch in splicing from anti-to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia. 2005 Nov; 48: 2422-7. doi: 10.1007/s00125-005-1951-8

Yang X, Deng Y, Gu H, Lim A, Altankhuyag A, Jia W, et al. Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. Molecular vision. 2011; 17: 3088.

Esteves J, Laranjeira AF, Roggia MF, Dalpizol M, Scocco C, Kramer CK, et al. Diabetic retinopathy risk factors. Arquivos Brasileiros de Endocrinologia & Metabologia. 2008; 52: 431-41. doi: 10.1590/S0004-27302008000300003

Al-Sarraf A, Al-Bannai S, Al-Furaih S, El-Shazly M. Prevalence and factors associated with diabetic retinopathy, a multi-centric study in Kuwait. Alexandria Journal of Medicine. 2010; 46(2): 99-108.